Clinical Trial Update: Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) [Phase 2]

View source ↗

Summary

This is an administrative update on the Phase 2b trial of EVO756 for chronic spontaneous urticaria, noting the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• EVO756

Snippet

Sponsor: Evommune, Inc. | Conditions: Chronic Spontaneous Urticaria | Phase 2 | Status: ACTIVE_NOT_RECRUITING